Literature DB >> 7480957

Major depression in a small group of adults with Down syndrome.

B A Myers1, S M Pueschel.   

Abstract

The clinical histories and treatment of the nine individuals with Down syndrome (DS) and major depression (MD) previously noted in a report on the psychopathology of a population of 164 adults with DS with and without health disorders from a Down Syndrome Clinic are presented (Myers & Pueschel, 1991). The clinical characteristics including DSM-III-R (1987) criteria of these 9 patients plus 13 individuals with DS and MD described in case reports in the literature are summarized. Depression is rarely verbalized and commonly appears as crying, depressed appearance, or mood lability. Vegetative symptoms of disinterest with severe withdrawal and mutism, psychomotor retardation, decreased appetite, weight loss, and insomnia are prominent. Verbal expression of preoccupations of suicide, death, self-depreciation, and guilt were infrequent and may either be not present or not reported due to mutism or moderate level of mental retardation (MR). Hallucinations were prominent. Family history of depression was infrequent. Psychological stressors were noted mostly in the study sample and not in the 13 from the literature. The pattern of vegetative symptomatology with few verbal complaints and prominent hallucinations may be related to moderate mental retardation in these groups with DS rather than specifically to DS.

Entities:  

Mesh:

Year:  1995        PMID: 7480957     DOI: 10.1016/0891-4222(95)00015-f

Source DB:  PubMed          Journal:  Res Dev Disabil        ISSN: 0891-4222


  8 in total

Review 1.  Prospects for improving brain function in individuals with Down syndrome.

Authors:  Alberto C S Costa; Jonah J Scott-McKean
Journal:  CNS Drugs       Date:  2013-09       Impact factor: 5.749

Review 2.  Neuropsychiatric and behavioral aspects of trisomy 21.

Authors:  Jeannie Visootsak; Stephanie Sherman
Journal:  Curr Psychiatry Rep       Date:  2007-04       Impact factor: 5.285

Review 3.  On the promise of pharmacotherapies targeted at cognitive and neurodegenerative components of Down syndrome.

Authors:  Alberto C S Costa
Journal:  Dev Neurosci       Date:  2011-09-02       Impact factor: 2.984

Review 4.  Neurologic complications of Down syndrome: a systematic review.

Authors:  Jonathan D Santoro; Dania Pagarkar; Duong T Chu; Mattia Rosso; Kelli C Paulsen; Pat Levitt; Michael S Rafii
Journal:  J Neurol       Date:  2020-09-12       Impact factor: 6.682

5.  Patterns of depressive symptoms and social relating behaviors differ over time from other behavioral domains for young people with Down syndrome.

Authors:  Kitty-Rose Foley; Jenny Bourke; Stewart L Einfeld; Bruce J Tonge; Peter Jacoby; Helen Leonard
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

6.  Psychiatric disorders in adolescents and young adults with Down syndrome and other intellectual disabilities.

Authors:  Elisabeth M Dykens; Bhavik Shah; Bruce Davis; Courtney Baker; Taylor Fife; Jeri Fitzpatrick
Journal:  J Neurodev Disord       Date:  2015-03-01       Impact factor: 4.025

7.  Acute neuropsychiatric disorders in adolescents and young adults with Down syndrome: Japanese case reports.

Authors:  Keiko Akahoshi; Hiroshi Matsuda; Masuko Funahashi; Tomoyuki Hanaoka; Yasuyuki Suzuki
Journal:  Neuropsychiatr Dis Treat       Date:  2012-07-30       Impact factor: 2.570

Review 8.  A Systematic Review of Unexplained Early Regression in Adolescents and Adults with Down Syndrome.

Authors:  Madeleine Walpert; Shahid Zaman; Anthony Holland
Journal:  Brain Sci       Date:  2021-09-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.